Treant Zorggroep
Treant Zorggroep
Emmen, Netherlands6 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| DUTCH Weight Control in Atrial Fibrillation Study | Arrhythmias, Cardiac, Body Weight, Body Weight Changes, Nutritional and Metabolic Diseases, Overweight, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Weight Loss, atrial fibrillation, cardiovascular disorder, heart disorder, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 4 | 2026-10-01 | NCT06184633 | |
| Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, neoplasm | Active, not recruiting | Phase 2 | 2026-08-21 | NCT03764553 | |
| Endocrine Therapy Plus CDK4/6 in First or Second Line for Hormone (SONIA) Receptor Positive Advanced Breast Cancer | Breast Neoplasm Female | Active, not recruiting | Phase 3 | 2026-05-20 | NCT03425838 | |
| Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 3 | 2025-12-03 | NCT07260435 | |
| Gut Microbiome Dynamics in Metastasized or Irresectable Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Not stated | 2025-01-01 | NCT03941080 | |
| What is the Optimal Antithrombotic Strategy in Patients With Atrial Fibrillation Undergoing PCI? | Arrhythmias, Cardiac, Arterial Occlusive Diseases, Embolism, Embolism and Thrombosis, Hemorrhage, Infarction, Necrosis, Non-ST Elevated Myocardial Infarction, Pathologic Processes, Pathological Conditions, Signs and Symptoms, ST-elevation myocardial infarction, acute coronary syndrome, arteriosclerosis disorder, atrial fibrillation, atrial flutter, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, coronary artery disorder, heart disorder, ischemic disease, myocardial infarction, myocardial ischemia, nervous system disorder, stroke disorder, thrombotic disease, vascular disorder | Recruiting | Phase 4 | 2023-12-15 | NCT04436978 |